[go: up one dir, main page]

BR9915436A - Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores - Google Patents

Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores

Info

Publication number
BR9915436A
BR9915436A BR9915436-6A BR9915436A BR9915436A BR 9915436 A BR9915436 A BR 9915436A BR 9915436 A BR9915436 A BR 9915436A BR 9915436 A BR9915436 A BR 9915436A
Authority
BR
Brazil
Prior art keywords
tumors
treatment
pharmaceutical compositions
compositions containing
certain substituted
Prior art date
Application number
BR9915436-6A
Other languages
English (en)
Inventor
Frederick Ray Kinder Jr
Kenneth Walter Bair
Christopher Turchik Jagoe
Richard William Versace
Sompong Wattanasin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9915436A publication Critical patent/BR9915436A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"CERTAS CAPROLACTAMAS SUBSTITUìDAS, COMPOSIçõES FARMACêUTICAS CONTENDO AS MESMAS E SEU USO NO TRATAMENTO DE TUMORES"<D>. A presente invenção refere-se a certos compostos de caprolactama substituída, às composições farmacêuticas contendo os ditos compostos, ao uso dos ditos compostos no tratamento de tumores e a um processo para fazer os ditos compostos.
BR9915436-6A 1998-11-17 1999-11-15 Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores BR9915436A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19335498A 1998-11-17 1998-11-17
PCT/EP1999/008767 WO2000029382A1 (en) 1998-11-17 1999-11-15 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors

Publications (1)

Publication Number Publication Date
BR9915436A true BR9915436A (pt) 2001-08-07

Family

ID=22713307

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915436-6A BR9915436A (pt) 1998-11-17 1999-11-15 Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores

Country Status (25)

Country Link
EP (1) EP1131297B1 (pt)
JP (1) JP3550545B2 (pt)
KR (1) KR20010080461A (pt)
CN (1) CN1187333C (pt)
AR (1) AR023914A1 (pt)
AT (1) ATE264309T1 (pt)
AU (1) AU748016B2 (pt)
BR (1) BR9915436A (pt)
CA (1) CA2347773C (pt)
CO (1) CO5140099A1 (pt)
CZ (1) CZ20011707A3 (pt)
DE (1) DE69916488T2 (pt)
ES (1) ES2221463T3 (pt)
HU (1) HUP0104224A3 (pt)
ID (1) ID28343A (pt)
IL (1) IL142701A0 (pt)
NO (1) NO20012428L (pt)
PE (1) PE20001241A1 (pt)
PL (1) PL347633A1 (pt)
PT (1) PT1131297E (pt)
SK (1) SK6692001A3 (pt)
TR (1) TR200101366T2 (pt)
UY (2) UY25807A1 (pt)
WO (1) WO2000029382A1 (pt)
ZA (1) ZA200103419B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085697A1 (en) * 2000-05-11 2001-11-15 Novartis Ag Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
WO2002072555A1 (en) * 2001-03-12 2002-09-19 Novartis Ag Process for preparing certain substituted caprolactams
JP2006528611A (ja) * 2003-07-25 2006-12-21 ノバルティス アクチエンゲゼルシャフト 置換ラクタムおよびそれらの抗がん剤としての使用
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
WO2011157787A1 (en) 2010-06-17 2011-12-22 Novartis Ag Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
JP2013532149A (ja) 2010-06-17 2013-08-15 ノバルティス アーゲー ピペリジニル置換１，３−ジヒドロ−ベンゾイミダゾール−２−イリデンアミン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge

Also Published As

Publication number Publication date
ES2221463T3 (es) 2004-12-16
EP1131297A1 (en) 2001-09-12
DE69916488D1 (de) 2004-05-19
NO20012428D0 (no) 2001-05-16
DE69916488T2 (de) 2005-03-24
AR023914A1 (es) 2002-09-04
TR200101366T2 (tr) 2001-10-22
JP3550545B2 (ja) 2004-08-04
EP1131297B1 (en) 2004-04-14
PL347633A1 (en) 2002-04-22
ATE264309T1 (de) 2004-04-15
SK6692001A3 (en) 2001-10-08
ZA200103419B (en) 2002-06-26
CO5140099A1 (es) 2002-03-22
PT1131297E (pt) 2004-08-31
PE20001241A1 (es) 2000-11-24
NO20012428L (no) 2001-07-17
UY26036A1 (es) 2001-06-29
HUP0104224A2 (hu) 2002-03-28
UY25807A1 (es) 2001-08-27
IL142701A0 (en) 2002-03-10
AU748016B2 (en) 2002-05-30
JP2002529536A (ja) 2002-09-10
CA2347773C (en) 2009-03-10
ID28343A (id) 2001-05-17
CN1326445A (zh) 2001-12-12
HUP0104224A3 (en) 2002-04-29
WO2000029382A1 (en) 2000-05-25
CZ20011707A3 (cs) 2001-08-15
CN1187333C (zh) 2005-02-02
CA2347773A1 (en) 2000-05-25
AU1506000A (en) 2000-06-05
KR20010080461A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
BR9812944A (pt) Inibidores bicìclicos da cinase
BRPI0408681A (pt) compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BR0213843A (pt) Derivado de quinazolina, processo para a preparação de um derivado de quinazolina, composição farmacêutica, e, uso de um derivado de quinazolina
BR9913383A (pt) Pirazol-carboxanilidas
BR0014939A (pt) Oligossacarìdeos, processo de preparação de oligossacarìdeos, composições farmacêuticas, e, utilização de oligossacarìdeos
LU91076I9 (en) 4&#34;-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
BR9007728A (pt) Composicao de hipoclorito de calcio solido,e processo para formar solucao aquosa de hipoclorito de calcio
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BRPI0107815B8 (pt) compostos derivados aminados de di-hidro-1,3,5- triazina, processo de preparo destes, composição farmacêutica e uso dos mesmos
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR9915436A (pt) Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
BR0008297A (pt) Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma
FR2734481B1 (fr) Pseudo-emulsions stabilisees et leur procede de preparation
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR9705143A (pt) Derivados de 10,13,15-trioxatriciclo [9.2.1.1(9.6)] -pentadecanona, processo para a sua preparação e medicamentos que contém estes compostos
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR0111897A (pt) Composto, método para tratar um indivìduo afligido por alguns distúrbios dos sistemas nervosos periférico e central, composição farmacêutica, e, uso de um composto
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements